Advertisement

Trigeminal Neuropathic Pain and Orofacial Neuralgias

  • David A. Sirois
  • Teekayu P. JornsEmail author
Chapter

Abstract

  • In a suspected trigeminal neuralgia scenario, it is important to rule out intracranial lesions (such as a mass or demyelination) as a source of pain through imaging. Intracranial lesion may be suspected if the patient is young, and there are neurologic deficits (e.g., loss of sensation, numbness) and loss of other sensory function including hearing, sight, or smell.

  • Neuropathic orofacial pain is often accompanied by other pain disorders such as myofascial pain or dental pulpitis. Management of any related disorders that contribute to hypersensitivity of the trigeminal nerve may be necessary to obtain improved relief from pharmacological management.

  • A multidisciplinary pain team approach is helpful to facilitate success in complex neuropathic pain patients with multiple pain disorders and contributing factors.

References

  1. 1.
    Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.CrossRefGoogle Scholar
  2. 2.
    Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, Treede RD, Zakrzewska JM, Nurmikko T. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87(2):220–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol. 1990;27(1):89–95.CrossRefPubMedGoogle Scholar
  4. 4.
    Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945–1984. Neuroepidemiology. 1991;10(5–6):276–81.CrossRefPubMedGoogle Scholar
  5. 5.
    Dworkin RH. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain. 2002;18:343–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Lipton JA, Ship JA, Larach D. Estimated prevalence of reported orofacial pain in the United States. J Am Dent Assoc. 1993;124:115–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Merrill RL. Intraoral neuropathy. Curr Pain Headache Rep. 2004;8:341–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Pogrel MA, Thamby S. Permanent nerve involvement resulting from inferior alveolar nerve blocks. JADA. 2000;131:901–7.PubMedGoogle Scholar
  9. 9.
    Haas DA, Lennon D. A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Can Dent Assoc. 1995;61(4):319–30.PubMedGoogle Scholar
  10. 10.
    Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Lai J, Hunter JC, Porreca F. The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol. 2003;13:291–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389–400.CrossRefPubMedGoogle Scholar
  13. 13.
    Jorns TP, Zakrzewska JM. Evidence-based approach to the medical management of trigeminal neuralgia. Br J Neurosurg. 2007;21(3):253–61.CrossRefPubMedGoogle Scholar
  14. 14.
    Fisher A, Zakrzewska JM, Patsalos PN. Trigeminal neuralgia: current treatments and future developments. Expert Opin Emerg Drugs. 2003;8(1):123–43.CrossRefPubMedGoogle Scholar
  15. 15.
    Ferrell Jr PB, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008;9(10):1543–6.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Reisner L, Pettengill C. The use of anticonvulsants in orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:2–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Zakrzewska JM. Trigeminal neuralgia. Clin Evid. 2003;9:1490–8.Google Scholar
  18. 18.
    Lopez BC. Hamlyn PJ. Zakrzewska JM. Systematic review of ablative neurosurgical techniques for the treatment of trigeminal neuralgia. Neurosurgery. 2004;54(4):973–82; discussion 982–3.Google Scholar
  19. 19.
    Dworkin R, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–34.CrossRefPubMedGoogle Scholar
  20. 20.
    Valmaseda-Castellón E, Berini-Aytés L, Gay-Escoda C. Inferior alveolar nerve damage after lower third molar surgical extraction: a prospective study of 1,117 surgical extractions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:377–83.CrossRefPubMedGoogle Scholar
  21. 21.
    McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffenband PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217–27.CrossRefPubMedGoogle Scholar
  22. 22.
    Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55:1–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome: a systematic review. J Orofac Pain. 2003;17(4):293–300.PubMedGoogle Scholar
  24. 24.
    Gremeau-Richard C, Woda A, Navez M, Attal N, Bouhassira D, Gagnieu M, Laluque J, Picard P, Pionchon P, Tubert S. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain. 2004;108:51–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Oral & Maxillofacial Pathology, Radiology and MedicineNew York University College of DentistryNew YorkUSA
  2. 2.Department of NeurologyNew York University School of MedicineNew York CityUSA
  3. 3.Department of Oral Biology, Faculty of DentistryKhon Kaen UniversityKhon KaenThailand

Personalised recommendations